IMMUNO-ONCOLOGY ASSAYS MARKET ANALYSIS

Immuno-Oncology Assays Market, By Product (Consumables and Software), By Technology (Immunoassay, PCR, NGS, Fow Cytometry, and Others), By Indication (Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, and Others), By Application (Clinical Diagnostics and Research and Development), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : May 2024
Code : CMI2632
Pages :165
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenge – Dearth of Skilled Professionals

Dearth of skilled professionals is expected to hinder growth of the global immuno-oncology assays market. For instance, there is a shortage of lab technicians, technologists, and possessing advanced laboratory expertise, a major factor that restrains growth of the market. Currently, Canada is facing a nation-wide shortage of lab technologists.

Market Opportunity – Increasing Collaborations Among Key Market Players

Increasing adoption of inorganic growth strategies such collaborations by the key market players is expected to drive the market growth over the forecast period. For instance, in May, 2021, the University of California, San Francisco (UCSF) in collaboration with the San Francisco Veteran Affairs (VA) Health Care System, the Prostate Cancer Foundation, launched the Drew Foundation Precision Oncology Center of Excellence, providing precision medicine treatments to veterans facing prostate cancer.